4.960USD+4.86%Mkt Cap: 116.35M USDP/E: —Last update: 2026-06-01
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on thera…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap116.35M USD
Enterprise Value62.34M USD
Revenue (TTM)7.94M USD
Gross Profit-8.80M USD
Net Income (TTM)-21.23M USD
Revenue/Share0.4360 USD
Last Price4.960 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.90
PEG—
EV/EBITDA-3.09
EV/Revenue7.85
P/S14.24
P/B2.31
EPS (TTM)-1.15
EPS (Forward)-1.66
52W Range
3.71031% of range7.750
52W High7.750 USD
52W Low3.710 USD
Profitability
Gross Margin-110.79%
Oper. Margin-3038.15%
EBITDA Margin-254.38%
Profit Margin-267.14%
ROE-49.33%
ROA-42.49%
Growth
Revenue Growth-2.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.74M USD
CapEx (TTM)—
FCF Margin-136.83%
FCF Yield-9.34%
Net Debt-50.72M USD
Net Debt/EBITDA2.51
Balance Sheet
Debt/Equity—
Current Ratio15.02
Quick Ratio14.30
Book Value/Sh2.088 USD
Cash/Share2.162 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)15.75 USD
Target Range14.00 USD – 18.00 USD
# Analysts6
Ownership
Shares Out.23.46M
Float17.83M
Insiders14.69%
Institutions35.37%
Short Interest
Short Ratio4.7d
Short % Float3.52%
Short % Out.3.49%
Shares Short818.10K
Short (prev mo.)771.97K
Technical
SMA 504.381 (+13.2%)
SMA 2005.321 (-6.8%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)160.69K
Avg Vol (10d)141.42K
Technical Indicators
RSI (14)54.0
MACD0.1111
MACD Signal0.0988
MACD Hist.+0.0123
BB Upper5.218 USD
BB Middle4.560 USD
BB Lower3.901 USD
BB Width28.88%
ATR (14)0.3035 USD
Vol Ratio (20d)0.61x